Referenser till artikeln "Nutrition och depression: aktuell forskning och behandling"
av Robert J. Hedaya, leg. Läkare

1) Rush A.J. ”STAR-D: What have we learned?” Am J Psychiatry. 2007;164-201.

2) Pigott et al. ”Efficacy and Effectiveness of Antidepressants: Current Status: Psychother Psychosom.” 2010;79(5):267-79.

3) Bourre J.M.”Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain: Part 1: micronutrients.” J Nutrition, Health & Aging: Vol 10(5) 2006: 377-385.

4) Miller H.L. et al. ”Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. ” Arch Gen Psychiatry. Vol.53(2):117-128.

5) Spillmann M.K. et al. ”Tryptophan depletion in SSRI recovered depressed outpatients.” Psychopharmacology (Berl)2001, May;155 (2):123-127

6) Maes M et al. ”Hypozincemia in depression.” J Affect Disord. 1994 Jun;31(2):135-40, Maes M. ”Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness.” Biol Psychiatry. 1997 Sep 1;42(5):349-58.

7) Maes M. et al. ”Lower serum zinc in major depression in relation to changes in serum acute phase proteins.” J Affect Disord 1999:56(2-3):189-194

8) Gilbody S. et al. ”Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review.” Am J Epidemiol. 2007 Jan 1;165(1):1-13.

9) Coppen A. et al. ”Enhancement of antidepressant action of fluoxetine by folic acid: a randomized, placebo controlled trial. ” J Affect Disord: 2000:60(Nov.):121-130.

10) Rutten B.P. ”Epigenetic mediation of environmental influences in major psychotic disorders.” Schizophrenia Bulletin; 2009: Vol 35 (6):1045-1056.

11) McGowan P.O. ”The epigenetics of social adversity in early life: Implications for mental health outcomes.” Neurobiol Dis. 2010 Jul;39(1):66-72.

12) Hedelin M. ”Dietary intake of fish, omega 3’s, omega 6 PUFA’s and vitamin D and the prevalence of psychotic symptoms in a cohort of 33,000 women from the general population.” BMC Psychiatry 2010 (10): 38; 1-13.

13) Wilkins C.H. et al. ”Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults.” Am J Geriatric Psychiatry, 2006 Dec;14(12):1032-40.

14) van Praag H.M. ”Depression, glucose tolerance, peripheral glucose uptake and their alterations under the influence of anti-depressive drugs of the hydrazine type.” Psychopharmacologia (Berlin) 1965;8:67-78.

15) Cassidy F. et al. ”Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients.” Am J Psychiatry 1999;156 1417-1420.

16) Weiss J.H. et.al. ”Zn(+2): a novel ionic mediator of neural injury in brain disease.” Trends Pharmacol Sci 2001: 21(12):112-3.

17) Lindenbaum J. et al. ”Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytois.” N Engl J Med 1988;318:1720-1728.

18) Vogiatzoglou A. ”Determinants of methylmalonic acid in a large population: Implications for assessment of vitamin B12 status.” Clin Chem. 2009 Dec;55(12):2198-206.